Haemonetics Corporation (NYSE: HAE), a global medical technology company that says it is focused on delivering innovative haematology solutions to drive better patient outcomes, has opened its new global headquarters in Boston, it was reported yesterday.

The new premises are intended support the company's work to build a collaborative, performance-driven culture, bringing together its corporate and commercial teams side by side with its research and development organisation in a contemporary environment.

The new Boston location occupies more than 62,000 square feet across four floors at 125 Summer Street, a modern, LEED Gold and Energy Star certified office tower.